Survivorship after neoadjuvant chemotherapy
Lancet Oncol
.
2022 Mar;23(3):e95.
doi: 10.1016/S1470-2045(22)00011-0.
Authors
Jin Zhang
1
,
Chaoyang Liang
1
,
Wenquan Niu
2
Affiliations
1
Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
2
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: niuwenquan_shcn@163.com.
PMID:
35240096
DOI:
10.1016/S1470-2045(22)00011-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy* / adverse effects
Survival
Survivorship*